The National Applied Research Laboratories (NARL), National Health Research Institutes and National Taiwan University (NTU) signed a memorandum of understanding establishing a magnetic resonance imaging (MRI) R&D and image service platform.
The platform will be set up at Hsinchu City-based Biomedical Science Park to promote high-level MRI use in such fields as basic biomedicine, animal modeling, preclinical research and translational medicine.
“Taiwan already has a wealth of talent and experience in basic and clinical MRI R&D, but the two fields are insufficiently integrated,” said NARL President Lo Ching-hua. “This agreement will provide domestic industry, academia, research institutes, and medical service providers with the necessary MRI R&D services to enhance the nation’s biomedical research capacity and promote clinical applications development.
“At the same time, the platform will improve the development of high-end MRI system R&D skills and establish autonomous software and hardware design and manufacturing capability. It will also serve to cultivate experience in product development, certification, management and manufacturing,” he added.
Lo said the new platform is expected to drive establishment of a domestic up, mid and downstream MRI production chain, turning Hsinchu Biomedical Science Park into Asia’s biomedical imaging R&D and applications hub.
“The vision of this tripartite cooperation is to make Taiwan home to the world’s most advanced integrated brain imaging platform,” NTU President Yang Pan-chyr said.
“The aim is to make the nation a world-leader in brain research and clinical applications, leading to development of new technology for the early diagnosis and treatment of disorders such as Alzheimer’s.